Objective To evaluate the applicability of fracture risk assessment tools in fracture risk prediction of patients with type 2 diabetes mellitus (T2DM) in Xinjiang. Methods The study included 1008 T2DM hospitalized patients. Age, gender, nationality, duration of diabetes, BMI, HbA1c, Ca, 25 (OH) D, bone mineral density (BMD) values, femoral neck T values, as well as the various risk factors in FRAX were recorded. Patients were divided into FRAX score group (FRAX/-, without BMD) and BMD T value group (with T value of femoral neck bone mineral density). The cutoff point of treatment in FRAX/- group was PHF ≥ 3% or PMOF ≥ 20%, and in BMD T value group was T value ≤ -2.5. Those who received same treatment recommendation were in the same group. Those who received different treatment recommendation were in the different group. Consistency analysis was carried out between the two groups to evaluate the applicability of FRAX in the specific population. Results With the increase of age, the risk of osteoporotic fracture increased. Higher BMD value reduced the risk of osteoporotic fractures. The fracture risk between different genders was also statistically significant (P<0.01). There were 961 patients in the same group and 47 in different groups. The consensus rate was 95.3% (961/1008). Among them, the differences in age, gender, and femoral neck T values were statistically significant (P<0.01). The age was younger, and the femoral neck T value and BMD value were higher in the same group than in the different group. Consistency using FRAX or femoral neck bone mineral density T values for the treatment decision showed that the Kappa value was 0.69 (P< 0.001). The area under the ROC curve of 10-year PHF and PMOF was 0.91 (P<0.01) and 0.898 (P<0.01), respectively. Conclusion FRAX/- and BMD T value have good consistency. The FRAX software can be used to accurately estimate and predict the fracture risk probability of T2DM population in Xinjiang. It provides accurate intervention recommendation. As a primary screening tool, FRAX can be promoted and applied in type 2 diabetes patients in China. |